Amyn Rojiani
Overview
Explore the profile of Amyn Rojiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johnson T, MacDonald T, Pacholczyk R, Aguilera D, Al-Basheer A, Bajaj M, et al.
Neuro Oncol
. 2023 Sep;
26(2):348-361.
PMID: 37715730
Background: Recurrent brain tumors are the leading cause of cancer death in children. Indoleamine 2,3-dioxygenase (IDO) is a targetable metabolic checkpoint that, in preclinical models, inhibits anti-tumor immunity following chemotherapy....
2.
Sahajpal N, Mondal A, Njau A, Ananth S, Jones K, Ahluwalia P, et al.
Future Microbiol
. 2020 Nov;
:1483-1487.
PMID: 33179525
RT-PCR-based assays for the detection of SARS-CoV-2 have played an essential role in the current COVID-19 pandemic. However, the sample collection and test reagents are in short supply, primarily due...
3.
Sahajpal N, Mondal A, Njau A, Ananth S, Jones K, Ahluwalia P, et al.
J Mol Diagn
. 2020 Aug;
22(10):1294-1299.
PMID: 32738298
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing has lagged in many countries because of test kit shortages and analytical process bottlenecks. This study investigated the feasibility and accuracy of...
4.
Sahajpal N, Njau A, Mondal A, Ananth S, Chaubey A, Rojiani A, et al.
Future Med Chem
. 2020 Jun;
12(17):1521-1523.
PMID: 32552003
No abstract available.
5.
6.
Chinnaiyan P, Chowdhary S, Potthast L, Prabhu A, Tsai Y, Sarcar B, et al.
Neuro Oncol
. 2011 Oct;
14(1):93-100.
PMID: 22028388
A phase I study was conducted to determine the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) for the combination of vorinostat with bevacizumab and CPT-11 in recurrent glioblastoma. Vorinostat...
7.
Barami K, Sloan A, Rojiani A, Schell M, Staller A, Brem S
J Clin Neurosci
. 2008 Dec;
16(2):195-201.
PMID: 19097905
The role of neural stem cells in gliomagenesis remains controversial. The aim of this study was to determine the anatomic relationship of human gliomas to the lining of the ventricular...
8.
Strickland-Marmol L, Khoor A, Livingston S, Rojiani A
Arch Pathol Lab Med
. 2007 Nov;
131(11):1686-90.
PMID: 17979487
Context: Brain metastases of adenocarcinoma of unknown primary pose a diagnostic dilemma to the surgical pathologist. Although the most common source in these cases is the lung, determining a primary...
9.
Robb J, Chalmers L, Rojiani A, Chamberlain M
Arch Neurol
. 2006 Jul;
63(7):1028-9.
PMID: 16831976
No abstract available.
10.
Wilcock D, Rojiani A, Rosenthal A, Subbarao S, Freeman M, Gordon M, et al.
J Neuroinflammation
. 2004 Dec;
1(1):24.
PMID: 15588287
BACKGROUND: Anti-Abeta immunotherapy in transgenic mice reduces both diffuse and compact amyloid deposits, improves memory function and clears early-stage phospho-tau aggregates. As most Alzheimer disease cases occur well past midlife,...